Risk of interstitial lung disease with gefitinib and...

Risk of interstitial lung disease with gefitinib and erlotinib in advanced non-small cell lung cancer: A systematic review and meta-analysis of clinical trials

Shi, Liang, Tang, Junfang, Tong, Li, Liu, Zhe
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
83
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2013.11.016
Date:
February, 2014
File:
PDF, 1.01 MB
english, 2014
Conversion to is in progress
Conversion to is failed